SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-091288
Filing Date
2011-04-07
Accepted
2011-04-07 16:16:00
Documents
12
Period of Report
2011-05-20
Effectiveness Date
2011-04-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 1439840
2 GRAPHIC g160692amgen_letterhead.jpg GRAPHIC 21059
3 GRAPHIC g160692david_scott.jpg GRAPHIC 8476
4 GRAPHIC g160692g03x50.jpg GRAPHIC 11189
5 GRAPHIC g160692g25x72.jpg GRAPHIC 12212
6 GRAPHIC g160692g38n85.jpg GRAPHIC 44581
7 GRAPHIC g160692g50r92.jpg GRAPHIC 177015
8 GRAPHIC g160692g83l22.jpg GRAPHIC 187609
9 GRAPHIC g160692g94a27.jpg GRAPHIC 13280
10 GRAPHIC g160692kevin_sharer.jpg GRAPHIC 6560
11 GRAPHIC g160692letterhead_002.jpg GRAPHIC 16940
12 GRAPHIC g160692recycle_symbol.jpg GRAPHIC 2556
  Complete submission text file 0001193125-11-091288.txt   2133667
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-12477 | Film No.: 11746436
SIC: 2836 Biological Products, (No Diagnostic Substances)